Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

US Patent 9834587 · Granted Dec 5, 2017

Estimated economic value: $41,485,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes an2025
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of 2022
Lysosomal targeting peptides and uses thereof2022
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof2022